Daniel specialises in advising and representing national and international clients in the life sciences sector. His focus is, among others, on all areas of pharmaceutical law, medical device law, pharmaceutical-advertising law, unfair competition law, and trademark law.

 

For more than 10 years, he has been coordinating and supervising disputes concerning competition law and trademark law for his clients and has, besides his specific focus on litigation, also longstanding experience in advising clients on regulatory and compliance matters, particularly, in the aforementioned areas of law. In context with managing litigation and advising his clients, Daniel is characterised by a strong client focus and his ability to find appropriate and efficient solutions to legal problems.

Afficher le CV complet Masquer le CV complet

Actualités et publications récentes

Sciences de la vie et Santé

LG Hamburg: Misleading advertising for therapeutic allergens with profitability

12 octobre 2023
Quick read

par Dr. Daniel Tietjen et Katharina Hölle

Cliquer ici pour en savoir plus
Sciences de la vie et Santé

Draft of a cannabis law for the further legalisation of cannabis in Germany

27 septembre 2023

par Dr. Daniel Tietjen et Ennio Schwind, LL.M. Eur.

Cliquer ici pour en savoir plus
Sciences de la vie et Santé

Legal requirements for green claims in advertising for medical devices

27 septembre 2023
Briefing

par Dr. Daniel Tietjen et Sherin Sayed

Cliquer ici pour en savoir plus
Sciences de la vie et Santé

OLG Brandenburg: Infringement of the price fixing for prescription-only medicinal products through granting cash discount for prompt payment

20 septembre 2023
Quick read

par Dr. Daniel Tietjen et Katharina Hölle

Cliquer ici pour en savoir plus